Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 8th May 2024 CTMX stock ended at $4.19. This is 2.95% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 10.95% from a day low at $3.79 to a day high of $4.21.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
May 27, 2016 $10.72 $10.78 $10.43 $10.62 131 057
May 26, 2016 $9.96 $10.81 $9.70 $10.62 162 098
May 25, 2016 $9.89 $10.12 $9.84 $10.03 71 875
May 24, 2016 $10.01 $10.04 $9.75 $9.88 61 255
May 23, 2016 $10.18 $10.43 $9.75 $9.98 73 759
May 20, 2016 $9.98 $10.24 $9.92 $10.10 29 130
May 19, 2016 $10.06 $10.38 $9.71 $9.88 45 868
May 18, 2016 $9.75 $10.34 $9.57 $10.18 76 545
May 17, 2016 $9.98 $10.18 $9.71 $9.80 79 709
May 16, 2016 $10.03 $10.46 $9.96 $10.00 93 667
May 13, 2016 $10.10 $10.66 $9.87 $10.00 69 660
May 12, 2016 $11.65 $11.70 $10.07 $10.11 166 860
May 11, 2016 $12.08 $12.19 $11.30 $11.32 51 731
May 10, 2016 $12.16 $12.34 $12.02 $12.15 21 350
May 09, 2016 $12.07 $12.51 $11.97 $12.08 54 262
May 06, 2016 $11.97 $12.40 $11.40 $12.11 31 693
May 05, 2016 $12.68 $12.70 $11.81 $12.10 58 690
May 04, 2016 $12.86 $13.17 $12.16 $12.56 95 030
May 03, 2016 $12.87 $13.33 $13.06 $13.06 13 711
May 02, 2016 $12.83 $13.35 $12.70 $13.06 58 967
Apr 29, 2016 $12.74 $13.17 $12.57 $12.92 25 255
Apr 28, 2016 $13.03 $13.34 $12.69 $12.81 36 993
Apr 27, 2016 $12.72 $13.33 $12.52 $13.22 24 031
Apr 26, 2016 $13.83 $13.71 $12.53 $12.82 103 353
Apr 25, 2016 $13.57 $13.95 $13.40 $13.70 69 722
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT